MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis

Abstract Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors of the digestive system, and its prevalence is currently increasing. The current study aims to elucidate the mechanism by which membrane-associated RING-CH8 (MARCH8) impedes the progression of HCC. MARCH8 was ident...

Full description

Saved in:
Bibliographic Details
Main Authors: Dao-yuan Tu, Rui Peng, Sheng-jie Jin, Bing-bing Su, Song-song Fan, Jia-hao Zhang, Shun-yi Wang, Yang-yang Miao, Guo-qing Jiang, Chi Zhang, Jun Cao, Dou-sheng Bai
Format: Article
Language:English
Published: Nature Publishing Group 2025-05-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07707-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849734051330523136
author Dao-yuan Tu
Rui Peng
Sheng-jie Jin
Bing-bing Su
Song-song Fan
Jia-hao Zhang
Shun-yi Wang
Yang-yang Miao
Guo-qing Jiang
Chi Zhang
Jun Cao
Dou-sheng Bai
author_facet Dao-yuan Tu
Rui Peng
Sheng-jie Jin
Bing-bing Su
Song-song Fan
Jia-hao Zhang
Shun-yi Wang
Yang-yang Miao
Guo-qing Jiang
Chi Zhang
Jun Cao
Dou-sheng Bai
author_sort Dao-yuan Tu
collection DOAJ
description Abstract Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors of the digestive system, and its prevalence is currently increasing. The current study aims to elucidate the mechanism by which membrane-associated RING-CH8 (MARCH8) impedes the progression of HCC. MARCH8 was identified as a distinct prognostic marker for recurrence-free survival (RFS) and overall survival (OS) in patients with HCC. This study shows that MARCH8 hinders lipid deposition by suppressing the expression of key enzymes for the de novo synthesis of fatty acids (FAs) via RNA sequencing, untargeted metabolomics, and a series of in vivo and in vitro experiments. Further experimental validation demonstrated that MARCH8 was a novel E3 ligase of sterol regulatory element binding protein 1 (SREBP1). And, it primarily promoted the degradation of SREBP1, thereby suppressing the expression of key enzymes involved in the de novo synthesis of FAs. In conclusion, this study has identified MARCH8 as a key “switch” that can be targeted to prevent de novo FA synthesis in HCC cells. This finding may have substantial implications for discovering innovative therapeutic strategies for HCC.
format Article
id doaj-art-7d659a190e8c4f5bb721f142bf46b830
institution DOAJ
issn 2041-4889
language English
publishDate 2025-05-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-7d659a190e8c4f5bb721f142bf46b8302025-08-20T03:07:54ZengNature Publishing GroupCell Death and Disease2041-48892025-05-0116111610.1038/s41419-025-07707-9MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesisDao-yuan Tu0Rui Peng1Sheng-jie Jin2Bing-bing Su3Song-song Fan4Jia-hao Zhang5Shun-yi Wang6Yang-yang Miao7Guo-qing Jiang8Chi Zhang9Jun Cao10Dou-sheng Bai11Department of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityDepartment of Hepatobiliary Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou UniversityAbstract Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors of the digestive system, and its prevalence is currently increasing. The current study aims to elucidate the mechanism by which membrane-associated RING-CH8 (MARCH8) impedes the progression of HCC. MARCH8 was identified as a distinct prognostic marker for recurrence-free survival (RFS) and overall survival (OS) in patients with HCC. This study shows that MARCH8 hinders lipid deposition by suppressing the expression of key enzymes for the de novo synthesis of fatty acids (FAs) via RNA sequencing, untargeted metabolomics, and a series of in vivo and in vitro experiments. Further experimental validation demonstrated that MARCH8 was a novel E3 ligase of sterol regulatory element binding protein 1 (SREBP1). And, it primarily promoted the degradation of SREBP1, thereby suppressing the expression of key enzymes involved in the de novo synthesis of FAs. In conclusion, this study has identified MARCH8 as a key “switch” that can be targeted to prevent de novo FA synthesis in HCC cells. This finding may have substantial implications for discovering innovative therapeutic strategies for HCC.https://doi.org/10.1038/s41419-025-07707-9
spellingShingle Dao-yuan Tu
Rui Peng
Sheng-jie Jin
Bing-bing Su
Song-song Fan
Jia-hao Zhang
Shun-yi Wang
Yang-yang Miao
Guo-qing Jiang
Chi Zhang
Jun Cao
Dou-sheng Bai
MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis
Cell Death and Disease
title MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis
title_full MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis
title_fullStr MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis
title_full_unstemmed MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis
title_short MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis
title_sort march8 suppresses hepatocellular carcinoma by promoting srebp1 degradation and modulating fatty acid de novo synthesis
url https://doi.org/10.1038/s41419-025-07707-9
work_keys_str_mv AT daoyuantu march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT ruipeng march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT shengjiejin march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT bingbingsu march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT songsongfan march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT jiahaozhang march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT shunyiwang march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT yangyangmiao march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT guoqingjiang march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT chizhang march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT juncao march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis
AT doushengbai march8suppresseshepatocellularcarcinomabypromotingsrebp1degradationandmodulatingfattyaciddenovosynthesis